Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2016, Vol. 12 ›› Issue (04): 425 -431. doi: 10.3877/cma.j.issn.1673-5250.2016.04.010

Special Issue:

Original Article

Research of number and migration ability of endothelial progenitor cells isolated from umbilical cord blood in preterm infants with different gestational ages

Meiyan Ni1, Xiaohong Bai1, Juan Chen1, Dapeng Chen1,()   

  1. 1. Department of Neonatology, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2016-02-01 Revised:2016-07-13 Published:2016-08-01
  • Corresponding author: Dapeng Chen
  • About author:
    Corresponding author: Chen Dapeng, Email:
Objective

To investigate the differences of the number and migration ability of endothelial progenitor cell (EPC) isolated from umbilical cord blood among preterm infants with different gestational ages.

Methods

From October 2014 to July 2015, a total of 47 cases of umbilical cord blood of neonates in West China Second University Hospital, Sichuan University, Sichuan Academy of Medical Sciences & Sichuan Provincial People′s Hospital, and Chengdu First People′s Hospital were chosen into this study. According to the gestational age of newborns whose umbilical cord blood was collected, they were divided into very preterm group (the gestational ages were 28 to 32 weeks, n=12), preterm group (the gestational ages were 32 to 36 weeks, n=20), and full-term group (the gestational ages were > 37 weeks, n=15). Before the induced differentiation of umbilical cord blood in the three groups, flow cytometry was used to detect the level of EPC. After the induced differentiation of umbilical cord blood in the three groups, the mononuclear cells were incubated and stained by fluorescent probes labeled Dil-acetylated low-density lipoprotein (Dil-Ac-LDL) and fluorescein isothiocyanate-labeled ulex europaeus agglutinin-1 (FITC-UEA-1). The stainings of mononuclear cells in the three groups were observed under fluorescence microscope to detect whether the EPC was successfully induced or not. Transwell migration assay was used to detect the migration ability of EPC in the three groups. The levels of EPC before the induced differentiation of umbilical cord blood in three groups and the migration numbers of EPC after the induced differentiation of umbilical cord blood in three groups were compared by statistical methods. The study protocol was approved by the Ethical Review Boards of three hospitals from which the umbilical cord blood was collected. Informed consent was obtained from each pregnant woman before obtaining umbilical cord blood. There were no significant differences in gender ratio, delivery method, Apgar scores and other basic data among the newborns from which the umbilical cord blood was collected in the three groups (P>0.05).

Results

①Flow cytometry results showed that, there was no statistical difference in the level of EPC before the induced differentiation of umbilical cord blood in the three groups (F=0.302, P=0.654). ②Dil-Ac-LDL and FITC-UEA-1 double fluorescent staining results showed that, EPC in the three groups all were successfully induced to differentiate from the umbilical cord blood, and with the increase of gestational age, the number of EPC induced from mononuclear cells increased gradually at the same time. ③Transwell migration experimental results show that, the migration number of EPC in very preterm group, preterm group and full-term group was (13.8±21.7) cells/field, (18.8±12.4) cells/field, (39.9±23.8) cells/field, respectively, and the difference was statistically significant (F=3.826, P=0.027). The migration number of EPC in very preterm group and preterm group were both significantly lower than that in full-term group, and both the differences were statistically significant (P=0.016, 0.035). The migration number of EPC in very preterm group was significantly lower than that in preterm group, and the difference was statistically significant (P=0.042).

Conclusions

With the increasing of gestational age, the level of EPC in preterm infants′ umbilical cord blood does not increase obviously, but the migration ability of EPC improves gradually as the gestational age increases.

表1 脐带血诱导分化前3组新生儿脐带血中内皮祖细胞水平比较(%, ±s)
图2 本研究3组新生儿脐带血中内皮祖细胞迁移数量情况(图2A:极早产儿组;图2B:早产儿组;图2C:足月儿组)(结晶紫溶液染色,高倍镜)
表2 本研究3组新生儿脐带血中内皮祖细胞迁移数量比较[个/视野,±s)
[1]
Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline membrane disease. Bronchopulmonary dysplasia[J]. N Engl J Med, 1967, 276(7): 357-368.
[2]
Radulova P, Vakrilova L, Slancheva B. Bronchopulmonary dysplasia: what do we know today?[J]. Akush Ginekol (Sofiia), 2015, 54(9): 37-43.
[3]
Minhajat R, Nilasari D, Bakri S. The role of endothelial progenitor cell in cardiovascular disease risk factors[J]. Acta Med Indones, 2015, 47(4): 340-347.
[4]
石琪,漆洪波. 早产的定义、分类及诊断[J]. 实用妇产科杂志,2012, 28(10): 801-803.
[5]
方立建. 人脐带血内皮祖细胞的培养与鉴定[D]. 长春:吉林大学,2008: 4-6.
[6]
Risau W. Mechanisms of angiogenesis[J]. Nature, 1997, 386(6626): 671-674.
[7]
吴甜,屈艺,母得志. 早产儿支气管肺发育不良的研究进展[J/CD]. 中华妇幼临床医学杂志:电子版,2016, 12(3): 339-343.
[8]
高原,刘花兰,包云光, 等. 支气管肺发育不良早产儿肝细胞生长因子、血管内皮生长因子水平变化及其相关性[J/CD]. 中华妇幼临床医学杂志:电子版,2015, 11(3): 48-52.
[9]
Balasubramaniam V, Mervis CF, Maxey AM, et al. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia[J]. Am J Physiol Lung Cell Mol Physiol, 2007, 292(5): L1073-L1084.
[10]
van Haaften T, Byrne R, Bonnet S, et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats[J]. Am J Respir Crit Care Med, 2009, 180(11): 1131-1142.
[11]
Javed MJ, Mead LE, Prater D, et al. Endothelial colony forming cells and mesenchymal stem cells are enriched at different gestational ages in human umbilical cord blood[J]. Pediatr Res, 2008, 64(1): 68-73.
[12]
Borghesi A, Massa M, Campanelli R, et al. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia[J]. Am J Respir Crit Care Med, 2009, 180(6): 540-566.
[13]
Qi Y, Jiang Q, Chen C, et al. Circulating endothelial progenitor cell decrease in infants with bronchopulmonary dysplasia and increase after inhaled nitric oxide[J]. PLoS One, 2013, 8(11): e79060.
[14]
Groenman F, Unger S, Post M. The molecular basis for abnormal human lung development[J]. Biol Neonate, 2005, 87(3): 164-177.
[15]
Bourbon J, Boucherat O, Chailley-Heu B, et al. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia[J]. Pediatr Res, 2005, 57 (5 Pt 2): 38R-46R.
[16]
Hansen AR, Barnés CM, Folkman J, et al. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia[J]. J Pediatr, 2010, 156(4): 532-536.
[17]
Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia[J]. N Engl J Med, 2006, 355(10): 992-1005.
[18]
Foidart JM, Schaaps JP, Chantraine F, et al. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia: a step forward but not the definitive answer[J]. J Reprod Immunol, 2009, 82(2): 106-111.
[19]
De Paepe ME, Greco D, Mao Q. Angiogenesis-related gene expression profiling in ventilated preterm human lungs[J]. Exp Lung Res, 2010, 36(7): 399-410.
[20]
Mailaparambil B, Krueger M, Heizmann U, et al. Genetic and epidemiological risk factors in the development of bronchopulmonary dysplasia[J]. Dis Markers, 2010, 29(1): 1-9.
[21]
Lashkari K, Hirose T, Yazdany J, et al. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity[J]. Am J Pathol, 2000, 156(4): 1337-1344.
[22]
Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis[J]. Science, 1997, 275(5302): 964-967.
[23]
Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia[J]. Circulation, 2001, 103(5): 634-637.
[24]
Yoder MC, Mead LE, Daniel P, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals[J]. Blood, 2007, 109(5): 1801-1809.
[25]
Richardson MR, Yoder MC. Endothelial progenitor cells: quo vadis?[J]. J Mol Cell Cardiol, 2011, 50(2): 266-272.
[26]
Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation[J]. Circulation, 2001, 103(6): 897-903.
[27]
Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo[J]. Nat Med, 2001, 7(9): 1035-1040.
[1] Chang Liu, Daxing Liu. Clinical research progress of cardiac allograft vasculopathy[J]. Chinese Journal of Transplantation(Electronic Edition), 2022, 16(04): 241-248.
[2] Shengnan Zhang, Dan Jia, Pinghui Sun, Haolin Teng. Analysis of influencing factors of chronic renal allograft dysfunction after renal transplantation[J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(03): 147-151.
[3] Ling Ling, Shuyu Chen. Application of parents-accompanied anesthesia induction combined with childern fun nursing in laparoscopic high ligation of inguinal hernia in children[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2021, 15(03): 307-311.
[4] Yanni Cui, Yan Ren, Fengting Liang, Yanhong Tan, Hongwei Wang. Clinical research and development progress of cord blood-derived product Omidubicel[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(03): 178-182.
[5] Jingxian Li, Xinglong Han, Yuanyuan Tu, Shijun Hu, Miao Yu, Wei Lei. Advances in endothelial progenitor cells in vascular injury repair[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2022, 12(03): 176-180.
[6] Xiaozuo Zhang, Haiqin Huo, Jianxin Tan, Fang Zhang, Haoyang Feng, Zhengfeng Xu. Development of neural tube-like models derived from pluripotent stem cells in vitro[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2022, 12(01): 45-50.
[7] Hua Li, Xiaofan Li, Nainong Li. Research advances ofumbilical cord blood stem cells proliferation promoted by mesenchymal stem cells in vitro[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2022, 12(01): 34-38.
[8] Long Chen, Bing Dong, Xiaolin Liu, Jiang He, Bingbo Yu, Lifang Luo, Wenhao Xia. Dual-modality imaging in vivo tracking for endothelial progenitor cells homing[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2021, 11(06): 351-357.
[9] Jie Xia, Zimeng Tang, Xiangwei Wu. Study on the adhesion of E-cadherin between endothelial progenitor cells and bone marrow mesenchymal stem cells[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2021, 11(06): 343-350.
[10] Yanyan Gao, Yanyan Pan, Yifan Jiang, Jun Ji, Li Zhang. Characterization and cardiac lineage differentiation potential of cardiogenic mesenchymal-like cells from human adults[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2021, 11(01): 16-24.
[11] Weifei Wang, Haiyan Yu, Xiaoling Yuan, Min Zhao, Min Wang, Qian Lu, Tian Wang, Dianrong Gong. Clinical effects of umbilical cord blood mononuclear cell transplantation on Parkinson's disease[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2020, 10(06): 341-345.
[12] Tingting Chen, Xueliang Jiang, Jiali Yu, Jianlin Ke. Safety of stem cells in the treatment of inflammatory bowel disease[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(04): 193-198.
[13] Jing Li, Lingling Zhang, Wei Xing. Value of concept of interest induction before anesthesia induction in pediatric surgery and its effect on family satisfaction[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 812-817.
[14] Yufang Yin, Yan Hai, Shaoling Li. Discussion on the timing of surgical position placement and evaluation of nursing effect in patients undergoing laparoscopic hiatal hernia repair[J]. Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), 2021, 08(01): 49-51.
[15] Xiaotang Ma, Chandi Li, Jiahui Li, Xiaobing Xu. The therapeutic effects of microRNA-17-enriched endothelial progenitor cell-derived exosomes on diabetic ischemic stroke[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2022, 16(04): 263-274.
Viewed
Full text


Abstract